Trials / Completed
CompletedNCT05673369
Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Condition
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-387 in healthy volunteers under fasting condition.
Detailed description
Evaluation of Pharmacokinetic profiles and Safety of CKD-387.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-387 | 1 Tablet |
| DRUG | D484 | 1 Tablet |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-02-11
- Completion
- 2023-02-27
- First posted
- 2023-01-06
- Last updated
- 2024-05-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05673369. Inclusion in this directory is not an endorsement.